These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 36222885

  • 1. Contemporary vs historical survival rates in metastatic clear cell renal carcinoma according to race/ethnicity.
    Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Nimer N, Tian Z, Larcher A, Capitanio U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI.
    World J Urol; 2022 Dec; 40(12):2971-2978. PubMed ID: 36222885
    [Abstract] [Full Text] [Related]

  • 2. Other-cause mortality and access to care in metastatic renal cell carcinoma according to race/ethnicity.
    Sorce G, Hoeh B, Hohenhorst L, Panunzio A, Tappero S, Tian Z, Larcher A, Capitanio U, Tilki D, Terrone C, Chun FKH, Antonelli A, Saad F, Shariat SF, Montorsi F, Briganti A, Karakiewicz PI.
    Urol Oncol; 2022 Nov; 40(11):493.e9-493.e16. PubMed ID: 35907705
    [Abstract] [Full Text] [Related]

  • 3. Survival of metastatic renal cell carcinoma patients continues to improve over time, even in targeted therapy era.
    Marchioni M, Bandini M, Pompe RS, Tian Z, Martel T, Kapoor A, Cindolo L, Berardinelli F, Briganti A, Shariat SF, Schips L, Karakiewicz PI.
    Int Urol Nephrol; 2017 Dec; 49(12):2143-2149. PubMed ID: 28932952
    [Abstract] [Full Text] [Related]

  • 4. Effect of African-American race on cancer specific mortality differs according to clear cell vs. non-clear cell histologic subtype in metastatic renal cell carcinoma.
    Marchioni M, Harmouch SS, Nazzani S, Bandini M, Preisser F, Tian Z, Kapoor A, Cindolo L, Briganti A, Shariat SF, Schips L, Karakiewicz PI.
    Cancer Epidemiol; 2018 Jun; 54():112-118. PubMed ID: 29715680
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Racial and ethnic differences in survival in contemporary metastatic renal cell carcinoma patients, according to alternative treatment modalities.
    Luzzago S, Palumbo C, Rosiello G, Knipper S, Pecoraro A, Nazzani S, Tian Z, Musi G, Montanari E, Shariat SF, Saad F, Briganti A, de Cobelli O, Karakiewicz PI.
    Cancer Causes Control; 2020 Mar; 31(3):263-272. PubMed ID: 31993859
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The effect of race/ethnicity on histological subtype distribution, stage at presentation and cancer specific survival in urethral cancer.
    Wenzel M, Deuker M, Stolzenbach F, Nocera L, Collà Ruvolo C, Tian Z, Shariat SF, Saad F, Briganti A, Kluth LA, Chun FKH, Karakiewicz PI.
    Urol Oncol; 2021 Jun; 39(6):369.e9-369.e17. PubMed ID: 33309509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The effect of race/ethnicity on cancer-specific mortality after salvage radical prostatectomy.
    Wenzel M, Würnschimmel C, Nocera L, Colla Ruvolo C, Hoeh B, Tian Z, Shariat SF, Saad F, Briganti A, Graefen M, Preisser F, Becker A, Mandel P, Chun FKH, Karakiewicz PI.
    Front Oncol; 2022 Jun; 12():874945. PubMed ID: 36059656
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.
    Würnschimmel C, Collà Ruvolo C, Nocera L, Wenzel M, Tian Z, Saad F, Briganti A, Shariat SF, Mirone V, Chun FKH, Tilki D, Graefen M, Karakiewicz PI.
    Eur Urol Focus; 2022 Jan; 8(1):191-199. PubMed ID: 33610487
    [Abstract] [Full Text] [Related]

  • 20. Effect of chemotherapy in metastatic prostate cancer according to race/ethnicity groups.
    Hoeh B, Würnschimmel C, Flammia RS, Horlemann B, Sorce G, Chierigo F, Tian Z, Saad F, Graefen M, Gallucci M, Briganti A, Terrone C, Shariat SF, Tilki D, Kluth LA, Mandel P, Chun FKH, Karakiewicz PI.
    Prostate; 2022 May; 82(6):676-686. PubMed ID: 35188981
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.